-
Graduate student Laura Bracaglia, with support from an American Heart Association graduate fellowship, is developing novel biomaterials based upon pericardial tissue.
-
Professor John Fisher and graduate student Tony Melchiorri are utilizing 3D printing strategies combined with biofunctionalization approaches to build functional vascular grafts for pediatric applications.
-
JHU/UMD Student Symposium, Drs. Martha Connolly and William Bentley discuss new bacterial sensing device with 2014 BIOE graduate.
-
Silver nanoparticles are inkjet-printed onto cellulose paper to generate flexible and low-cost chemical and biomolecular sensors.
-
Dr. Ian White with three BS BIOE graduates at the 2014 Graduation
About M-CERSI
The University of Maryland's Center of Excellence in Regulatory Science and Innovation (M-CERSI) is funded by the U.S. Food and Drug Administration (FDA). The center focuses on modernizing and improving the ways drugs and medical devices are reviewed and evaluated.
The center is a collaborative partnership between the University of Maryland, College Park, and the University of Maryland in Baltimore. Researchers from both campuses work with FDA staff to support the development of new tools, standards and approaches to assess the safety, efficacy, quality and performance of FDA-regulated products. Through the M-CERSI, researchers, regulators and industry professionals can learn from one other in the effort to develop regulatory science practices that promote innovation in medical devices and pharmaceuticals, while also addressing critical safety concerns.
This website highlights regulatory science activities at the center and coalesces center research projects into an information-rich resource base. The site will be populated with articles and opinion statements by M-CERSI researchers.
Collaborating Partners:
